Prevalence and correlates of microvascular complications among patients with diabetes mellitus: a cross sectional study

Ashok Kumar, Ardaman Singh, Vikram S. Tanwar, Nikhil Govil


Background: Diabetes mellitus is a metabolic disorder of multiple etiology, characterized by chronic hyperglycemia and associated with various microvascular, macrovascular and nonvascular complications leading to increasing morbidity and mortality. Microvascular complications are daibetes specific and their relation with associated comorbidities studied worldwide. To estimate the prevalence of microvascular complications in diabetic patients and to find their relation with various comorbid conditions.

Methods: A total of hundred diagnosed patients of diabetes mellitus with age ranging from 18 to 75 years were enrolled in the study. Patients were assessed for the presence of microvascular complications and associated comorbidities. The effect of various comorbidities on frequency of microvascular complications was also determined. Data collected was statistically analyzed.

Results: In this study, the mean age of the study group was 55.77±11.75 years. Mean age of onset of the disease was 48.89±11.50 years. Mean duration of the disease in the study group was 6.86±5.02 years. Diabetic retinopathy, neuropathy and nephropathy was found in 76%, 63% and 69% patients, respectively. Among patients with hypertension, 91.7%, 83.3%, and 81.7% cases were found to have retinopathy, neuropathy and nephropathy, respectively. The corresponding figures for those with comorbid IHD were 91.1%, 83.9% and 76.8% respectively whereas among patients with coexisting metabolic syndrome, 92.5%, 80.6%, and 79.1% were found to have retinopathy, neuropathy, and nephropathy, respectively.

Conclusions: The most frequent microvascular complication reported by this study was diabetic retinopathy. comorbid conditions like hypertension, ischemic heart disease, and metabolic syndrome were associated with higher prevalence of microvascular complications in diabetic patients.


Hypertension, Ischemic heart disease, Microvascular complications, Metabolic syndrome

Full Text:



Guariguata L, Whiting D, Weil C, Unwin N. The International Diabetes Federation Diabetes Atlas Methodology for Estimating Global and National Prevalence of Diabetes in Adults. Diabetes Res Clin Pract 2011;94(3):322‐32.

Anjana RM, Pradeepa R, Deepa M, Dutta M, Sudha V, Unnikrishnan R, et al. Prevalence of diabetes and prediabetes (impaired fasting glucose and / or impaired glucose tolereance) in urban and rural India: phase 1 results of the Indian Council of Medical research India diabetes (ICMR-INDIAB) study. Diabetologia. 2011;54(12):3022-7.

Powers AC. Diabetes Mellitus: Diagnosis, Classification, and Pathophysiology. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J editors. Harrison’s Principles Internal Medicine. 19th edn. New York: McGrawHill; 2399-2407.

Powers AC. Diabetes Mellitus: Complications. In: Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J editors. Harrison’s Principles Internal Medicine. 19th ed. New York: McGrawHill; 2422-2430.

Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Executive summary of the third report of the National Cholesterol Education Program (NCEP). 2001;285:2486-97.

Agrawal RP, Ranka M, Beniwal R, Sharma S, Purohit VP, Kochar DK et al. Prevalence of micro and macro vascular complications in type 2 diabetes and their risk factors. Int J Diab Dev Countries. 2004;24:11-8.

Idriss KS, Kanoun F, Hsaïri H, Machgoul M, Bahri M, Ben KF, et al. Population. Tunis Med. 2002;80(7):380-6.

Lepore G, Bruttomesso D, Nosari I, Tiengo A, Trevisan R. Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients. Diabetes Nutr Metab. 2002;15(4):232-9.

Amari F. Long term complications of type 1diabetes mellitus. Diabetologia Croatica. 2004;33-2.

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998;317(7160):703-13.

Gall MA, Hougaard P, Borch-Johnsen K, Parving HH. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study. BMJ. 1997;314:783-8.

Ebeling P, Koivisto VA. Occurrence and interrelationships of complications in insulin-dependent diabetes in Finland. Acta Diabetol. 1997;34(1):33-8.

Lepore G, Bruttomesso D, Nosari I, Tiengo A, Trevisan R. Glycaemic control and microvascular complications in a large cohort of Italian type 1 diabetic out-patients. Diabetes Nutr Metab. 2002;15(4):232-9.

Dyck PJ, Kratz JM, Karnes JL, Litchy WJ, Klein R, Pach JM, et al. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology. 1993;43(4):817-24.

Rema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V. Prevalence of diabetic retinopathy in urban India: The Chennai Urban Rural Epidemiology Study (CURES) Eye Study. I. Invest Ophthalmol Vis Sci 2005;46:2328-33.

Liu Z, Fu C, Wang W, Xu B. Prevalence of chronic complications of type 2 diabetes mellitus in outpatients - a cross-sectional hospital-based survey in urban China. Health Qual Life Outcomes 2010;8:62.

Pedro RA, Ramon SA, Marc BB, Juan FB, Isabel MM. Prevalence and relationship between diabetic retinopathy and nephropathy, and its risk factors in the North-East of Spain. Ophthamic Epidemiol. 2010;17(4):251-65.

Ahamed A, Shantha GP, Agarwal G, Senthil N, Paunikar N, Sudhakar MK. Prevalence of microvascular complications in metabolic syndrome in comparison to type 2 diabetes mellitus. J Indian Med Assoc. 2008;106(9):583-8.